Laurus Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE947Q01028
  • NSEID: LAURUSLABS
  • BSEID: 540222
INR
1,364.00
-4.95 (-0.36%)
BSENSE

Jun 18

BSE+NSE Vol: 14.13 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Anthem Bioscienc
Biocon
Glenmark Pharma
Laurus Labs
Dr Reddy's Labs
Abbott India
Zydus Lifesci.
Lupin
Mankind Pharma
Aurobindo Pharma
Alkem Lab
Why is Laurus Labs Ltd ?
1
High Management Efficiency with a high ROCE of 16.75%
2
With a growth in Net Profit of 993.4%, the company declared Very Positive results in Sep 25
  • The company has declared positive results for the last 4 consecutive quarters
  • PAT(Latest six months) At Rs 357.99 cr has Grown at 1,006.62%
  • PBT LESS OI(Q) At Rs 242.77 cr has Grown at 1233.17%
  • NET SALES(Latest six months) At Rs 3,223.04 cr has Grown at 33.26%
3
High Institutional Holdings at 37.63%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
  • Along with generating 73.57% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Laurus Labs should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Laurus Labs for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Laurus Labs
105.19%
2.09
35.25%
Sensex
-5.16%
0.44
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.19%
EBIT Growth (5y)
-0.72%
EBIT to Interest (avg)
6.35
Debt to EBITDA (avg)
1.94
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
0.89
Tax Ratio
24.71%
Dividend Payout Ratio
12.15%
Pledged Shares
2.69%
Institutional Holding
39.79%
ROCE (avg)
15.97%
ROE (avg)
14.59%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
83
Industry P/E
34
Price to Book Value
13.95
EV to EBIT
58.85
EV to EBITDA
42.96
EV to Capital Employed
9.91
EV to Sales
11.21
PEG Ratio
0.56
Dividend Yield
0.15%
ROCE (Latest)
16.84%
ROE (Latest)
16.77%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
ROCE(HY)

Highest at 17.30%

OPERATING PROFIT TO INTEREST(Q)

Highest at 12.66 times

NET SALES(Q)

Highest at Rs 1,811.57 cr

PBDIT(Q)

Highest at Rs 512.11 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 28.27%

PBT LESS OI(Q)

Highest at Rs 349.57 cr.

PAT(Q)

Highest at Rs 279.14 cr.

EPS(Q)

Highest at Rs 5.17

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Laurus Labs
Operating Profit to Interest - Quarterly
Highest at 12.66 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Quarterly
Highest at Rs 1,811.57 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 512.11 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 28.27%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 349.57 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 349.57 cr has Grown at 37.75%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 279.14 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 5.17
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)